dc.contributor.author | De Oliveira Melo, Nathalia Caroline | |
dc.contributor.author | Cuevas Sierra, Amanda | |
dc.contributor.author | Arellano García, Laura | |
dc.contributor.author | Portillo Baquedano, María Puy | |
dc.contributor.author | Milton Laskibar, Iñaki | |
dc.contributor.author | Martínez, J. Alfredo | |
dc.date.accessioned | 2024-05-30T15:09:09Z | |
dc.date.available | 2024-05-30T15:09:09Z | |
dc.date.issued | 2023-10 | |
dc.identifier.citation | Journal of Functional Foods 109 : (2023) // Article ID 105808 | es_ES |
dc.identifier.issn | 1756-4646 | |
dc.identifier.issn | 2214-9414 | |
dc.identifier.uri | http://hdl.handle.net/10810/68286 | |
dc.description.abstract | High-fat High-fructose diets have been associated with metabolic disorders and gut microbiota dysbiosis. Thus, the administration of probiotic or postbiotic from the strain Lacticaseibacillus rhamnosus GG has been investigated as a protective strategy. The aim of this study was to analyze the impact of L. rhamnosus GG administration in rodents fed a high-fat high-fructose diet. Male Wistar rats with oral supplementation of L. rhamnosus GG, viable or heat-inactivated, for 6 weeks were evaluated for somatic measurements, food and energy intake, biochemical markers, and gut microbiota. The daily administration of L. rhamnosus GG, as probiotic or postbiotic, was beneficial in attenuating weight gain, visceral fat deposition and visceral hypertriglyceridemic phenotype. Furthermore, the administration of heat-inactivated L. rhamnosus GG elicited an increase of species such as Akkermansia muciniphila, Blautia glucerasea, Sarcina maxima and L. rhamnosus, where the interaction between L. rhamnosus and Blautia glucerasea attenuated metabolic markers altered by the obesogenic diet. | es_ES |
dc.description.sponsorship | This work was supported by Instituto de Salud Carlos III (CIBERobn) under Grant CB12/03/30007), the Basque Government under Grant IT1482-22 and Synergic R&D Projects in New and Emerging Scientific Areas on the Frontier of Science and Interdisciplinary Nature of The Community of Madrid (METAINFLAMATIONY2020/BIO-6600). Laura Isabel Arellano-García is a recipient of a doctoral fellowship from the Basque Government. Amanda Cuevas-Sierra is a recipient of a postdoctoral grant Sara Borrell from Instituto Carlos III. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Elsevier | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/es/ | * |
dc.subject | Akkermansia muciniphila | es_ES |
dc.subject | Blautia glucerasea | es_ES |
dc.subject | high fructose intake | es_ES |
dc.subject | Lacticaseibacillus rhamnosus | es_ES |
dc.subject | postbiotic | es_ES |
dc.subject | probiotic | es_ES |
dc.title | Oral administration of viable or heat-inactivated Lacticaseibacillus rhamnosus GG influences on metabolic outcomes and gut microbiota in rodents fed a high-fat high-fructose diet | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.rights.holder | © 2023 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/). | es_ES |
dc.rights.holder | Atribución-NoComercial-SinDerivadas 3.0 España | * |
dc.relation.publisherversion | https://www.sciencedirect.com/science/article/pii/S1756464623004085 | es_ES |
dc.identifier.doi | 10.1016/j.jff.2023.105808 | |
dc.departamentoes | Farmacia y ciencias de los alimentos | es_ES |
dc.departamentoeu | Farmazia eta elikagaien zientziak | es_ES |